SLV308, Antiparkinsonian Antidepressive, Anxiolytic, Partial Dopamine D2 Agonist 5-HT1A Agonist

R. Feenstra; E. Ronken; T. Koopman; M. de Vries; A. McCreary; M. Stoker; K. van Charldorp; S. Long; G.J.M. van Scharrenburg

SLV308, Antiparkinsonian Antidepressive, Anxiolytic, Partial Dopamine D2 Agonist 5-HT1A Agonist

R. Feenstra, E. Ronken, T. Koopman, M. de Vries, A. McCreary, M. Stoker, K. van Charldorp, S. Long, G.J.M. van Scharrenburg

extern

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	128-132
Number of pages	5
Journal	Drugs of the Future
Volume	26
Publication status	Published - 2001

Cite this

@article{66ec6c803f1d43d0b7b4ba64ccab6fb3,

title = "SLV308, Antiparkinsonian Antidepressive, Anxiolytic, Partial Dopamine D2 Agonist 5-HT1A Agonist",

author = "R. Feenstra and E. Ronken and T. Koopman and {de Vries}, M. and A. McCreary and M. Stoker and {van Charldorp}, K. and S. Long and {van Scharrenburg}, G.J.M.",

year = "2001",

language = "Undefined/Unknown",

volume = "26",

pages = "128--132",

journal = "Drugs of the Future",

issn = "0377-8282",

publisher = "Prous Science",

}

TY - JOUR

T1 - SLV308, Antiparkinsonian Antidepressive, Anxiolytic, Partial Dopamine D2 Agonist 5-HT1A Agonist

AU - Feenstra, R.

AU - Ronken, E.

AU - Koopman, T.

AU - de Vries, M.

AU - McCreary, A.

AU - Stoker, M.

AU - van Charldorp, K.

AU - Long, S.

AU - van Scharrenburg, G.J.M.

PY - 2001

Y1 - 2001

M3 - Article

SN - 0377-8282

VL - 26

SP - 128

EP - 132

JO - Drugs of the Future

JF - Drugs of the Future

ER -